Liver Cirrhosis Complications
Mostrando 1-12 de 38 artigos, teses e dissertações.
-
1. NEW IMMUNIZATION SCHEDULE EFFECTIVENESS AGAINST HEPATITIS B IN LIVER TRANSPLANTATION PATIENTS
RESUMO CONTEXTO: O transplante de fígado, apesar de ser um procedimento de elevado risco, está consolidado como recurso terapêutico para cura e melhoria da qualidade de vida de indivíduos acometidos por doenças. A prevenção da infecção pelo vírus da hepatite B através da vacinação tem sido a medida mais efetiva para reduzir complicações, dim
Arq. Gastroenterol.. Publicado em: 07/11/2019
-
2. EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARS
RESUMO CONTEXTO: A doença hepática gordurosa não alcoólica vem sendo diagnosticada com frequência progressivamente maior na população geral, como consequência do aumento da prevalência da obesidade e do diabetes mellitus tipo 2, considerados seus principais fatores de risco. Caracteriza-se por acúmulo de gordura nos hepatócitos associada à infl
Arq. Gastroenterol.. Publicado em: 30/09/2019
-
3. MULTIVARIATE ANALYSIS OF BILIARY FLOW-RELATED FACTORS AND POST-KASAI SURVIVAL IN BILIARY ATRESIA PATIENTS
RESUMO CONTEXTO: A atresia biliar representa a principal causa de colestase tratada cirurgicamente durante o período neonatal. Se a criança não for operada, ela evolui invariavelmente para cirrose biliar secundária. OBJETIVO: Avaliar, através de análise multivariada, os fatores prognósticos associados à presença de fluxo biliar e à sobrevida co
Arq. Gastroenterol.. Publicado em: 20/05/2019
-
4. Refractory ascites and graft dysfunction in early renal transplantation
Resumo A ocorrência de ascite no pós-Transplante Renal (TR) é infrequente, podendo ser consequência de complicações cirúrgicas ou médicas. Caso clínico: 61 anos, masculino, antecedentes de hipertensão arterial, carcinoma da língua e hábitos alcoólicos 12-20g/dia. Doença renal crônica secundária à doença renal poliquística autossômica domi
J. Bras. Nefrol.. Publicado em: 18/03/2019
-
5. Cardiac Disorder in Chronic Hepatitis C
Abstract Chronic hepatitis C (CHC) has a high prevalence in the world. In addition to hepatic complications with cirrhosis in about 20% of patients and high risk for hepatocarcinoma, extrahepatic manifestations may also occur. Cardiac involvement in patients with CHC is associated with several factors, such as increased risk for coronary artery disease, prim
Int. J. Cardiovasc. Sci.. Publicado em: 07/03/2019
-
6. Escala Perme como preditor de funcionalidade e complicações após a alta da unidade de terapia intensiva em pacientes submetidos a transplante hepático
RESUMO Objetivo: Avaliar a pontuação da escala Perme de mobilidade como preditor de funcionalidade e complicações no pós-operatório de pacientes submetidos a transplante hepático. Métodos: A amostra foi composta por 30 pacientes que realizaram transplante hepático. Os pacientes foram avaliados em dois momentos, a fim de verificar a percepção da
Rev. bras. ter. intensiva. Publicado em: 2019-03
-
7. Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is a common disease associated with metabolic syndrome and can lead to life-threatening complications like hepatic carcinoma and cirrhosis. Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist antidiabetic drug, has the capacity to overcome insulin resistance and attenuate hepatic steatosis but the specific
Braz J Med Biol Res. Publicado em: 14/06/2018
-
8. An analysis of tacrolimus-related complications in the first 30 days after liver transplantation
OBJECTIVES: Orthotopic liver transplantation has improved survival in patients with end-stage liver disease; however, therapeutic strategies that achieve ideal immunosuppression and avoid early complications are lacking. To correlate the dose and level of Tacrolimus with early complications, e.g., rejection, infection and renal impairment, after liver trans
Clinics. Publicado em: 2014-11
-
9. Esteato-hepatite não alcoólica e esteatose em hepatite crônica pelo vírus C: prevalência e relações entre dados demográficos e clínico-laboratoriais com parâmetros histopatológicos / Nonalcoholic steatohepatitis and steatosis in chronic hepatitis C: prevalence and the relationship between demographic, clinical and laboratory data with histopathological parameters
Chronic hepatitis C is the leading cause of progressive liver damage and related complications, such as cirrhosis and primary hepatocellular carcinoma. Fibrosis stage and necro-inflammatory activity grade are good predictors of disease progression in chronic hepatitis C (CHC).The global epidemic of obesity and diabetes are associated with the increasing inci
Publicado em: 2010
-
10. Análise dos fatores de risco para peritonite bacteriana espontânea em pacientes cirróticos e do perfil da flora infectante com o uso de antibióticos profiláticos / Analysis of risk factors for spontaneous bacterial peritonitis in cirrhotic patients and the ascitic fluid microbiology with use of prophylactic antibiotics
INTRODUCTION: Invasive procedures and the decline of the liver function have been considered predisposing factors for spontaneous bacterial peritonitis (SBP) in cirrhotic patients. In spite of the predominance of gram negative, the incidence of gram positive agents is increasing in literature. OBJETIVES: To analyze the risk factors for SBP in cirrhotic patie
Publicado em: 2009
-
11. Histological response study of chronic viral hepatitis C patients treated with interferon alone or combined with ribavirin
Chronic hepatitis C is often a progressive, fibrotic disease that can lead to cirrhosis and other complications. The recommended therapy is a combination of interferon and ribavirin. Besides its antiviral action, interferon is considered to have antifibrotic activity. We examined the outcome of hepatic fibrosis and inflammation in chronic hepatitis C patient
Brazilian Journal of Infectious Diseases. Publicado em: 2008-10
-
12. Simultaneous detection of the C282Y, H63D and S65C mutations in the hemochromatosis gene using quenched-FRET real-time PCR
Hereditary hemochromatosis (HH) is a common autosomal disorder of iron metabolism mainly affecting Caucasian populations. Three recurrent disease-associated mutations have been detected in the hemochromatosis gene (HFE): C282Y, H63D, and S65C. Although HH phenotype has been associated with all three mutations, C282Y is considered the most relevant mutation r
Brazilian Journal of Medical and Biological Research. Publicado em: 30/09/2008